Skip to main content
Premium Trial:

Request an Annual Quote

Celera to Distribute AlphaGene s cDNA Database

NEW YORK, Nov. 13 - AlphaGene announced Tuesday that it had entered into an agreement with Celera Genomics, which will distribute AlphaGene's set of full-length human clones.


Celera will make this data available through its subscription database both to academic and commercial researchers.


By the terms of the agreement, AlphaGene will isolate known clones from public databases. Celera will map those clone sequences to its human genome database.


AlphaGene, a Woburn, Mass.-based functional genomics company, will also be responsible for sequencing and manufacturing the clones.


Financial terms of the agreement were not disclosed, although Celera will market the effort.

The company focuses on gene expression in degenerative neurological diseases like Parkinson's and Alzheimer's, and has constructed more than 200 cDNA libraries from major organs and tissues in the body. More than half of the gene inventory is derived from neurological tissue.


The Scan

WHO Seeks Booster Pause

According to CNN, the World Health Organization is calling for a moratorium on administering SARS-CoV-2 vaccine boosters until more of the world has received initial doses.

For Those Long Legs

With its genome sequence and subsequent RNAi analyses, researchers have examined the genes that give long legs to daddy longlegs, New Scientist says.

September Plans

The New York Times reports that the US Food and Drug Administration is aiming for early September for full approval of the Pfizer-BioNTech SARS-CoV-2 vaccine.

Nucleic Acids Research Papers on Targeting DNA Damage Response, TSMiner, VarSAn

In Nucleic Acids Research this week: genetic changes affecting DNA damage response inhibitor response, "time-series miner" approach, and more.